<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR/STTR Phase II:     Automated Analyzer for Drug Delivery Systems</AwardTitle>
<AwardEffectiveDate>10/01/2002</AwardEffectiveDate>
<AwardExpirationDate>09/30/2005</AwardExpirationDate>
<AwardTotalIntnAmount>499378.00</AwardTotalIntnAmount>
<AwardAmount>594136</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>F.C. Thomas Allnutt</SignBlockName>
</ProgramOfficer>
<AbstractNarration>This Small Business Innovation Research Phase II project will develop a new analytical tool for characterizing drug delivery aerosols and powders. This instrument will be based on a previously developed aerosal mass spectrometer that provides real-time size distribution and chemical composition measurements for aerosol particles. During Phase I research, a new inlet for the aerosol mass spectrometer, allowing  detection of particles in the size range relevant to inhalable drug delivery aerosols and powders (2 to 10 mm in diameter), was successfully developed. The key objectives of the Phase II project are :  (a) to further improve the collection efficiency for particles in the 2 to 10 mm diameter size range ; (b) to design and construct a sampling apparatus that conforms to Food and Drug Administration (FDA) and U. S. Pharmacopeia Convention (USP) guidelines for sampling drug delivery aerosols from metered dose inhalers (MDIs) and dry powder inhalers (PDIs); and (c)to develop and to validate an analytical method that meets FDA standards.&lt;br/&gt;&lt;br/&gt;The commercial applications of this project will be in the area of drug delivery.</AbstractNarration>
<MinAmdLetterDate>09/17/2002</MinAmdLetterDate>
<MaxAmdLetterDate>06/08/2005</MaxAmdLetterDate>
<ARRAAmount/>
<AwardID>0216220</AwardID>
<Investigator>
<FirstName>Douglas</FirstName>
<LastName>Worsnop</LastName>
<EmailAddress>worsnop@aerodyne.com</EmailAddress>
<StartDate>09/17/2002</StartDate>
<EndDate>04/10/2003</EndDate>
<RoleCode>Former Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Leah</FirstName>
<LastName>Williams</LastName>
<EmailAddress>williams@aerodyne.com</EmailAddress>
<StartDate>04/10/2003</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Aerodyne Research Inc</Name>
<CityName>BILLERICA</CityName>
<ZipCode>018213976</ZipCode>
<PhoneNumber>9789320231</PhoneNumber>
<StreetAddress>45 MANNING RD STE 2</StreetAddress>
<CountryName>United States</CountryName>
<StateName>Massachusetts</StateName>
<StateCode>MA</StateCode>
</Institution>
<FoaInformation>
<Code>0203000</Code>
<Name>Health</Name>
</FoaInformation>
<FoaInformation>
<Code>0308000</Code>
<Name>Industrial Technology</Name>
</FoaInformation>
<ProgramElement>
<Code>5373</Code>
<Text>SBIR Phase II</Text>
</ProgramElement>
<ProgramReference>
<Code>7218</Code>
<Text>RET SUPP-Res Exp for Tchr Supp</Text>
</ProgramReference>
<ProgramReference>
<Code>9102</Code>
<Text>WOMEN, MINORITY, DISABLED, NEC</Text>
</ProgramReference>
<ProgramReference>
<Code>9178</Code>
<Text>UNDERGRADUATE EDUCATION</Text>
</ProgramReference>
<ProgramReference>
<Code>9181</Code>
<Text>BIOPROCESSING/BIOMOLECULAR MATERIALS</Text>
</ProgramReference>
<ProgramReference>
<Code>9251</Code>
<Text>REU SUPP-Res Exp for Ugrd Supp</Text>
</ProgramReference>
<ProgramReference>
<Code>BIOT</Code>
<Text>BIOTECHNOLOGY</Text>
</ProgramReference>
</Award>
</rootTag>
